| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 26 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 26 |
| 2 | TACROLIMUS OINTMENT 0.1% | 26 |
| 3 | PREDNISONE | 20 |
| 4 | LISINOPRIL | 14 |
| 5 | BEVACIZUMAB | 13 |
| 6 | RANITIDINE | 13 |
| 7 | MYCOPHENOLATE MOFETIL | 12 |
| 8 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 12 |
| 9 | ASPIRIN | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SILICONE | 1 | 0.0385 |
| 1 | COCAINE HYDROCHLORIDE NASAL | 1 | 0.0154 |
| 2 | PROPOFOL INJECTABLE EMULSION | 1 | 0.0090 |
| 3 | PORACTANT ALFA | 2 | 0.0027 |
| 4 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 1 | 0.0013 |
| 5 | DINUTUXIMAB | 1 | 0.0012 |
| 6 | ETOMIDATE INJECTION | 2 | 0.0009 |
| 7 | DEFEROXAMINE MESYLATE | 2 | 0.0009 |
| 8 | ETOMIDATE | 2 | 0.0009 |
| 9 | ROPIVACAINE HYDROCHLORIDE | 2 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Surfactant [EPC] | 2 | 0.0017 |
| 1 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 10 | 0.0005 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 4 | 0.0005 |
| 4 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 6 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 2 | 0.0002 |
| 7 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 8 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 9 | Penem Antibacterial [EPC] | 4 | 0.0001 |